Government Plans Overhaul of CBEC to Ensure Seamless GST Implementation Ryanair Posts Record 226 Billion Annual Profit Up 40 Despite Boeing Delivery Delays and Fuel Uncertainty UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Posing Regulatory Risk to Platforms Market Wrap SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags The Hidden Cost of Lifestyle Creep Why Higher Earnings Dont Always Mean Financial Security Trainline Lifts Guidance Again Signaling Strong Momentum MAZE Q1 2026 Earnings EPS Surprises to the Upside Revenue Yet to Materialize CARE Q1 2026 Earnings EPS Falls 857 Below Consensus Shares Slip MKC Q1 2026 Earnings Strong EPS Beat Amid Market Challenges NTRS Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher APEI Q1 2026 Earnings EPS Surges Past Estimates with 383 Beat SmartRent Q1 2026 Earnings EPS Misses Estimates as Stock Declines Southwest Airlines LUV Edges Higher as Traders Eye Key Resistance Levels Alphatec Holdings ATEC Slides 25 Key Levels to Watch Amid Market Pressure Eaton Vance California Municipal Income Trust CEV Holds Steady Near Key Support Levels SilverBox Corp V SBXE Holds Steady at 998 as SPAC Trading Remains Muted RLI Corp RLI Edges Lower Testing Support Territory Near 4993 SOMN Q1 2026 Earnings EPS Surpasses Estimates on Operational Efficiency Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise WHFCL Q1 2026 Earnings Bond Performance in Focus Amid EPS Miss and Flat Revenue Reporting IN8bio Inc INAB Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Rises GNTX Q1 2026 Earnings EPS Beats Estimates with 381 Surprise as Shares Dip Slightly Sera Prognostics Q1 2026 Earnings EPS Meets Estimates as Stock Rises 15 on Operational Progress US Payrolls Surge Past Estimates in April But Economic Concerns Emerge SPOK Q1 2026 Earnings EPS Misses Estimates by Over 50 Shares Dip 21 IGD Trades Slightly Higher Amid RangeBound Conditions Support and Resistance in Focus FIBK Q1 2026 Earnings Slight Earnings Miss Amidst Steady Operations Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares ACAD Q1 2026 Earnings EPS Falls Short of Estimates Despite Slight Stock Uptick MRNA Q1 2026 Earnings NarrowerThanExpected Loss Despite Revenue Absence Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues ARGX Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Flat Stock Reaction HELE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction